Does central monitoring dramatically impact data quality? Proactively identifying risks throughout a clinical trial is invaluable in maintaining patient safety and research reliability, and statistical data monitoring (SDM) may be an effective method of improving clinical trial conduct and associated data. We put this theory to the test in an analysis of more than 1,000 sites in over 150 trials across varying therapeutic areas and study phases. Curious about the results? Join our webinar to unpack some of the most important insights from the study and discussing their implications for your organization.
